Language: BG BG
← Back to results
Active (not recruiting) Not applicable NCT06045962

Optimal Stent Duration After Ureteroscopy

No applicable phase (e.g. observational)
Conditions: Ureteral Stent

Sponsor: Mayo Clinic

trial.available_in: БГ
Overview
The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
Description
The rationale for this study is to determine if there is a difference in symptoms or complications among patients undergoing uncomplicated ureteroscopy for stone removal with shorter indwelling stent duration. Currently there are only a few small studies exploring the optimal duration of stent placement after stent placement and no multicenter randomized control trials. The investigation aim is to determine if earlier ureteral stent removal will reduce urinary symptoms after stent removal and improve quality of life without increasing risk of negative side effects. Using questionnaires for stent related symptoms the researchers will assess stent indwelling time effect on patient reported side effects.
Who can participate
Inclusion Criteria * Participants undergoing unilateral stone treatment. Patients may have stones present bilaterally, but must only be having unilateral intervention. * The ureteroscopy must be uncomplicated * Patients undergoing semi-rigid ureteroscopy only, flexible ureteroscopy only, or a combination Exclusion Criteria * Pregnancy * A stent or nephrostomy tube placed prior to surgery * Complex ureteroscopy - ureteral injury, ureteral perforation, ureteral stricture, impacted stone * Infection or struvite stones * Recurrent Urinary Tract Infection (UTI): 2 culture proven UTI in 6 months or 3 culture proven UTIs in one year * No stone evident on ureteroscopic evaluation of ureter or kidney * Transplant kidney * Variant anatomy (horseshoe, pelvic kidney)
Interventions
Ureteral stent
DEVICE
Locations 11
Canada (2)
University of Montreal
Montreal , Quebec
University of British Columbia
Vancouver , British Columbia
United States (9)
Johns Hopkins University
Baltimore , Maryland
University of North Carolina
Chapel Hill , North Carolina
Cleveland Clinic
Cleveland , Ohio
Vanderbilt University
Nashville , Tennessee
Mayo Clinic Arizona
Phoenix , Arizona
Mayo Clinic Minnesota
Rochester , Minnesota
University of California San Diego
San Diego , California
Montefiore Medical Center
The Bronx , New York
University of Arizona
Tucson , Arizona
Technical details
Status
Active (not recruiting)
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
01.11.2023
Completion date
01.09.2026
Registry ID
NCT06045962
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.